Regulation of hPTH Expression In Virto Using the Tetracycline Inducible Retrovirus Vector System

Tetracycline Inducible Retrovirus Vector System을 이용한 In Vitro에서의 인간 부갑상선 호르몬의 발현 조절

  • Koo, Bon-Chul (Department of Physiology, Catholic University of Daegu School of Medicine) ;
  • Kwon, Mo-Sun (Department of Physiology, Catholic University of Daegu School of Medicine) ;
  • Kim, Te-Oan (Department of Physiology, Catholic University of Daegu School of Medicine)
  • 구본철 (대구가톨릭대학교 의과대학 생리학교실) ;
  • 권모선 (대구가톨릭대학교 의과대학 생리학교실) ;
  • 김태완 (대구가톨릭대학교 의과대학 생리학교실)
  • Published : 2006.09.30

Abstract

Endogenous 84 amino acid parathyroid hormone(PTH) is synthesized as a pre-pro hormone by the chief cells of the parathyroid glands. Physiological actions of PTH include regulation of bone metabolism, renal tubular reabsorption of calcium and phosphate, and intestinal calcium absorption. In addition, PTH stimulates new bone formation by extraordinary stimulation of osteoblastic activity and decreasing calcium excretion by the kidney. In this study, we constructed and tested retrovirus vectors designed to express the human parathyroid hormone(hPTH) gene under the control of the tetracycline-inducible promoters. To increase the hPTH gene expression at turn-on state, woodchuck hepatitis virus posttranscriptional regulatory element(WPRE) sequence was also introduced into retrovirus vector at downstream region of either the hPTH gene or the sequence encoding reverse tetracycline-controlled transactivator(rtTA). Transformed primary culture cells(porcine fetal fibroblast, PFF, chicken embryonic fibroblast, CEF) were cultured in the medium supplemented with or without doxycycline(tetracycline derivative) for 48 hours, and induction efficiency was measured by comparing the hPTH gene expression level using two step RT-PCR and ELISA Higher hPTH expression($3{\tims}10^4\;pg/ml,\;5.3{\times}10^4\;pg/ml$) and tighter expression control(up to 8 fold) were observed from the vector in which the WPRE sequence was placed at downstream of the hPTH gene. The resulting tetracycline inducible vector system may be helpful in solving serious physiological disturbance problems which have been a major obstacle in successful production of transgenic animals.

본 연구에서는 인간 부자상선 호르몬의 발현을 유도적으로 조절할 수 있는 retrocvirus vector system을 확립하고자 하였다. 이에 tetracycline계 물질로 발현을 유도적으로 조절할 수 있는 one vector 형태의 Tet-On system을 이용하였으며 WPRE 서열을 도입하여 유도적 조건에서 외래 유전자의 발현을 증가시켰다. 구축한 각각의 표적세포에서 RT-PCR과 ELISA를 이용하여 hPTH유전자의 발현 정도를 비교 측정한 결과, WPRE가 hPTH의 3' 위치에 도입된 $RevTRE-PTH-WPRE-CMVp-rtTA2^sM2$ virus를 이용하여 유전자를 전이시킨 경우에 hPTH의 발현량이 가장 높은 것으로 나타났고, 또한 유도율도 가장 큰 것으로 확인되었다. 이 system을 이용하여 생산한 고감염가의 virus는 인간의 부갑상선 호르몬을 생산하기 위한 동물세포주의 구축이나 형질전환 동물의 생산에 있어서 매우 효율적인 유전자 전이 수단이 될 것으로 사료된다.

Keywords

References

  1. Canalis E (2000): Novel treatments for osteoporosis. J Clin Invest 106:177-179 https://doi.org/10.1172/JCI10584
  2. Chenuaud P, Larcher T, Rabinowitz JE, Provost N, Joussemet B, Bujard H, Samulski RJS, Favre D, Moullier P (2004): Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle. Mol Ther 9:410-418 https://doi.org/10.1016/j.ymthe.2003.12.015
  3. Donello JE, Jonathan EL, Hope TJ (1998): Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Viol 72:5085-5092
  4. Gossen M, Bujard H (1992): Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89: 5547-5551
  5. Gossen M, Freundlieb S, Bender G, Millier G, Hillen W, Bujard H (1995): Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766-1769 https://doi.org/10.1126/science.7792603
  6. Heaney R (2003): Advances in therapy for osteoporosis. Clin Med Res 2:93-99
  7. Hofmann A, Nolan GP, Blau HM (1996): Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc Natl Acad Sci USA 93:5185-5190
  8. Hu SX, Ji W, Zhou Y, Logothetis C, Xu HJ (1997): Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression. Cancer Res 57:3339-3343
  9. Iida A, Chen S-T, Friedmann T, Yee J-K (1996): Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system. J Virol 70:6054-6059
  10. Juppner H, Gardella TJ, Brown EM, Kronenberg HM, Potts JT Jr (2001): Parathyroid hormone, and parathyroid hormone-related peptide in the regulation of calcium homeostasis and bone development; in DeGroot LJ, Jameson JL (eds): Endocrinology, ed 4. Philadelphia, Saunders, 969-998
  11. Lamartina S, Roscilli G, Rinaudo CD, Sporeno E, Silvi L, Hillen W, Bujard H, Cortese R, Ciliberto G, Toniatti C (2002): Stringent control of gene expression in vivo by using Novel Doxycycline-Dependent trans-activators. Hum Gene Ther 13:199-210 https://doi.org/10.1089/10430340252769734
  12. Marzio G, Verhoef K, Vink M, Berkhout B (2001): In vitro evolution of a highly replicating, doxycycline-dependent HlV for applications in vaccine studies. Proc Natl Acad Sci USA 98:6342-6347
  13. Milhaud G, Labat ML, Moricard Y (1983): (Dichloromethylene) diphosphonate-induced impairment of T-lymphocyte function. Proc Natl Acad Sci USA 80:4469-4473
  14. Miller AD, Miller DG, Garcia JV, Lynch CM (1993): Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217:581-599 https://doi.org/10.1016/0076-6879(93)17090-R
  15. Pluta K, Luce MJ, Bao L, Agha-Mohammadi S, Reiser J (2005): Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters. J Gene Med 7:803-817 https://doi.org/10.1002/jgm.712
  16. Popa I, Harris ME, Donello JE, Hope TJ (2002): CRM1-dependent function of a cis-acting RNA export element. Mol Cell BioI 22:2057-2067 https://doi.org/10.1128/MCB.22.7.2057-2067.2002
  17. Qu Z, Thottassery JV, Van Ginkel S, Manuvakhova M, Westbrook L, Roland-Lazenby C, Hays S, Kern FG (2004): Homogeneity and long-term stability of tetracycline-regulated gene expression with low basal activity by using the rtTA2S-M2 transactivator and insulator-flanked reporter vectors. Gene 327:6173 https://doi.org/10.1016/j.gene.2003.10.029
  18. Ramezani A, Hawley TS, Hawley RG (2000): Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol Ther 2:458-469 https://doi.org/10.1006/mthe.2000.0190
  19. Rendahl KG, Leff SE, Otten GR, Spratt SK, Bohl D, Van Roey M, Donahue BA, Cohen LK, Mandel RJ, Danos O, Snyder RO (1998): Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat Biotechnol 16:757-761 https://doi.org/10.1038/nbt0898-757
  20. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W (2000): Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 97:7963-7968
  21. Verhoef K, Marzio G, Hillen W, Bujard H, Berkhout B (2001): Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J Virol 75:979-987 https://doi.org/10.1128/JVI.75.2.979-987.2001
  22. Yoshida Y, Hamada H (1997): Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal. Biochem Biophys Res Commun 230:426-430 https://doi.org/10.1006/bbrc.1996.5975
  23. Zhu Z, Zheng T, Lee CG, Homer RJ, Elias JA (2002): Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling. Cell Develop Biol 13:121-128 https://doi.org/10.1016/S1084-9521(02)00018-6
  24. Zufferey R, Donello JE, Trono D, Hope TJ (1999): Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Viol 73:2886-2892